← Back to Search

Stent-Graft

Stent-Graft for Aortic Aneurysm

N/A
Recruiting
Led By Linda M Reilly, MD
Research Sponsored by Timothy Chuter, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aneurysm of the aortic arch larger than 6cm in diameter, or symptomatic aneurysm of the aortic arch, of any diameter, or any arch aneurysm with a 2-year rupture rate estimated to be more than 20%.
Suitable arterial anatomy for stent-graft
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial is testing a new operation to fix aortic aneurysms that involves placing a stent-graft over the aneurysm.

Who is the study for?
This trial is for individuals with aortic arch aneurysms larger than 6cm, symptomatic of any size, or at high risk of rupture. Candidates must be able to consent and follow the study plan, have a life expectancy over 2 years, and not suitable for open repair surgery due to high mortality risk.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of using an endovascular bifurcated stent-graft to treat aortic arch aneurysms. The procedure involves placing this special tube inside the artery without open surgery.See study design
What are the potential side effects?
Potential side effects may include complications related to the device like movement after placement, blockage or infection; reactions from contrast material used during implantation; and general risks associated with minimally invasive procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a large or symptomatic aortic arch aneurysm, or one likely to rupture.
Select...
My arteries are suitable for a stent-graft procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Successful implantation of bifurcated stent-graft for repair of Aneurysm involving the proximal aortic arch
Secondary outcome measures
Stability of bifurcated stent-graft for repair of Aneurysm involving the proximal aortic arch

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionalExperimental Treatment1 Intervention
Endovascular Bifurcated Stent Graft: The investigational operation involves placing a stent-graft over the aortic aneurysm.

Find a Location

Who is running the clinical trial?

Timothy Chuter, MDLead Sponsor
1 Previous Clinical Trials
250 Total Patients Enrolled
1 Trials studying Aortic Aneurysm
250 Patients Enrolled for Aortic Aneurysm
Linda M Reilly, MDPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
300 Total Patients Enrolled
1 Trials studying Aortic Aneurysm
300 Patients Enrolled for Aortic Aneurysm

Media Library

Endovascular Bifurcated Stent-Graft (Stent-Graft) Clinical Trial Eligibility Overview. Trial Name: NCT00488696 — N/A
Aortic Aneurysm Research Study Groups: Interventional
Aortic Aneurysm Clinical Trial 2023: Endovascular Bifurcated Stent-Graft Highlights & Side Effects. Trial Name: NCT00488696 — N/A
Endovascular Bifurcated Stent-Graft (Stent-Graft) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00488696 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research team actively enrolling participants for this experiment?

"Yes, according to the information available on clinicaltrials.gov, this medical trial is still in search of participants. It was first posted back on October 1st 2006 and then updated most recently on July 21st 2021. Currently they are looking for 25 patients at a single location."

Answered by AI

What is the sample size of participants in this research endeavor?

"Affirmative. Clinicaltrials.gov shows that this trial, first created on October 1st 2006, is currently seeking recruits; 25 individuals in total from a single clinical site are needed to complete the study."

Answered by AI
Recent research and studies
~1 spots leftby Dec 2024